Palantir's Swiss Court Loss and Political Squeeze Deepen Its Stock Woes

Zurich court rejects Palantir's claims, stock near year low; new AI oversight bill and UK scrutiny add risk despite strong Q1 revenue growth.

A Swiss legal setback has added a fresh layer of friction for Palantir, even as the company’s commercial engine hums along. The Zurich Commercial Court dismissed almost all of the data analytics firm’s demands for counter-statements against the magazine Republik, granting only one of 23 requests. Palantir now shoulders the bulk of the legal costs, which run to roughly 19,000 Swiss francs.

The ruling lands at a moment when the stock is already under severe pressure. At Friday’s close of €110.66, shares have shed about 23% since the start of the year. That leaves the stock 38% below its 52-week high of €179.98 and perilously close to the year’s low of €104.96 — just 5% above it. The short-term technical picture is just as uncomfortable: the price sits roughly 7% under the 50-day moving average and almost 20% below the 200-day line, with the relative strength index hovering around 40.

What has really shifted the narrative, however, is the mounting political headwinds around Palantir’s core defense business. Senator Adam Schiff introduced legislation in June that would mandate human oversight for any AI-driven military decisions, effectively barring the Pentagon from fielding fully autonomous weapons. The bill directly targets the kind of systems Palantir provides. Earlier, Anthropic CEO Dario Amodei drew attention to a US military operation in Iran that reportedly relied on Palantir software — though he stressed a human made the final call.

Across the Atlantic, scrutiny of Palantir’s government ties is also intensifying. In the UK, the company’s role in the NHS’s national data platform is drawing growing criticism over patient-data access, with the government reportedly weighing an exit clause. While such contracts were once viewed as a moat, they are increasingly seen as headline risk. As one observer put it: in a bull market the government connection looked like indispensable infrastructure; in a correction it looks like a vulnerability.

Institutional investors are sending mixed signals. Norway’s sovereign wealth fund took a massive new stake worth $5.15 billion, and Arrowstreet Capital added to its position. But others have pulled back: Artemis Wealth Advisors slashed its holdings significantly. The divergence suggests a market that cannot decide whether Palantir’s AI premium is justified.

On the operational side, the company continues to deliver. First-quarter revenue surged nearly 85% year over year to $1.63 billion, beating analyst expectations, and higher margins have boosted operating profit. New multiyear enterprise contracts point to strong commercial adoption of its AI platform beyond government clients. Yet the market is no longer rewarding AI exposure indiscriminately. The bar for growth has risen, and investors demand evidence, not just narrative.

This week’s macro calendar adds another layer. The Federal Reserve is set to decide on interest rates, with retail sales and jobless claims also due. A shortened trading week — markets are closed Friday for Juneteenth — concentrates the data. For richly valued AI and software stocks, interest-rate expectations directly influence how future growth is discounted.

The most immediate technical test is the support zone around €105. If that level breaks, further selling could follow. But the bigger question is whether the market will begin to separate durable AI infrastructure from hype-driven momentum. Palantir can still win that distinction — if the focus stays on real deployments and revenue. But for now, at €110.66, the premium has to be earned anew every day.